This trial looked at the outcomes of using the Actis Total Hip System in cementless primary THA and hemi-hip arthroplasty procedures. Clinical, radiographic, and device and procedure related adverse event assessments were used to evaluate the performance of the system.
- Femoral Neck Fractures in Elderly
- Rheumatoid Arthritis
- Posttraumatic Osteoarthritis
- Femoral Neck Fracture
- Non-union of Femoral Neck Fractures
- Congenital Hip Dysplasia
- Avascular Necrosis of the Femoral Head
1 Primary · 5 Secondary · Reporting Duration: 2 Years
Awards & Highlights
0 Treatment Group
255 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
How many participants are participating in this clinical investigation?
"Affirmative. According to the information provided by clinicaltrials.gov, this medical trial was first published on July 1st 2016 and is still actively seeking enrolment from 255 patients at a single site." - Anonymous Online Contributor
Are applications still being taken for this medical study?
"Per the information available on clinicaltrials.gov, recruitment for this trial is still ongoing and began on July 1st 2016. The last update was made November 28th 2022." - Anonymous Online Contributor